Back to Journals » International Journal of Nanomedicine » Volume 14

Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles

Authors Iturrioz-Rodríguez N, Correa-Duarte MA, Fanarraga ML

Received 19 December 2018

Accepted for publication 11 March 2019

Published 8 May 2019 Volume 2019:14 Pages 3389—3401

DOI https://doi.org/10.2147/IJN.S198848

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Cristina Weinberg

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Anderson Oliveira Lobo


Nerea Iturrioz-Rodríguez,1 Miguel A Correa-Duarte,2,3 Mónica L Fanarraga1

1Nanomedicine Group, University of Cantabria – IDIVAL, Santander, 39011, Spain; 2Department of Physical Chemistry, Center for Biomedical Research (CINBIO), Southern Galicia Institute of Health Research (IISGS), Vigo 36310, Spain; 3Biomedical Research Networking Center for Mental Health (CIBERSAM), Universidade de Vigo, Vigo 36310, Spain

Abstract: The implementation of nanotechnology in medicine has opened new research horizons particularly in the field of therapeutic delivery. Mesoporous silica particles have emerged as biocompatible drug delivery systems with an enormous potential in the treatment of cancer among many other pathologies. In this review, we focus on the unique properties of these particles as chemotherapy delivery carriers. Here, we summarize the general characteristics of these nanomaterials – including their physicochemical properties and customizable surfaces – different stimuli that can be used to trigger targeted drug release, biocompatibility and finally, the drawbacks of these types of nanomaterials, highlighting some of the most important features of mesoporous silica nanoparticles in drug delivery.

Keywords: nanocarrier, drug release, targeted drug delivery, biocompatibility, biodegradability, tumor

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]